Literature DB >> 10806141

Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics.

G M Gauvreau1, J M Lee, R M Watson, A M Irani, L B Schwartz, P M O'Byrne.   

Abstract

Mast cells and basophils are metachromatic cells that participate in allergic inflammation. Allergen challenge to the airways of atopic asthmatic individuals increases levels of metachromatic cells, which may reflect an increase in mast cells, basophils, or both. We conducted a study to characterize the kinetics of basophil and mast cell recruitment to the airways of atopic asthmatic subjects after allergen inhalation challenge, using monoclonal antibodies specific for each type of cell. Of 19 subjects, 14 developed both early- and late-phase asthmatic responses (dual responders [DRs]), whereas five developed only early asthmatic responses (early responders [ERs]) after allergen inhalation. There was a significant increase in the number of sputum eosinophils (p < 0.002) and basophils (p < 0.002) at 7 h and 24 h after challenge in both ERs and DRs. There was also a significant increase in the number of activated eosinophils (p = 0. 00002) and mast cells (p = 0.009) in sputum at 7 h and 24 h after challenge in DRs, but not in ERs (p > 0.4). DRs had a significantly higher number of allergen-induced sputum basophils than did ERs (p < 0.01), and sputum basophils correlated significantly with airway hyperresponsiveness (AHR) to methacholine at 24 h after challenge (r = 0.66, p = 0.002). DRs tended to have higher allergen-induced basophil levels than did ERs, which may contribute to the observed AHR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806141     DOI: 10.1164/ajrccm.161.5.9908090

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  39 in total

Review 1.  Basophils in airway disease.

Authors:  Donald MacGlashan; Gail Gauvreau; John T Schroeder
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

2.  Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma.

Authors:  Ryan H Dougherty; Sukhvinder S Sidhu; Kavita Raman; Margaret Solon; Owen D Solberg; George H Caughey; Prescott G Woodruff; John V Fahy
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

Review 3.  New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation.

Authors:  Mark C Siracusa; Michael R Comeau; David Artis
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

4.  When is a mouse basophil not a basophil?

Authors:  James J Lee; Michael P McGarry
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

Review 5.  Understanding allergic asthma from allergen inhalation tests.

Authors:  Donald W Cockcroft; Fredrick E Hargreave; Paul M O'Byrne; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2007-10       Impact factor: 2.409

Review 6.  Newly discovered roles for basophils: a neglected minority gains new respect.

Authors:  Hajime Karasuyama; Kaori Mukai; Yusuke Tsujimura; Kazushige Obata
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

7.  Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity.

Authors:  Mahboobeh Mahdavinia; Roderick G Carter; Christopher J Ocampo; Whitney Stevens; Atsushi Kato; Bruce K Tan; Robert C Kern; David B Conley; Rakesh Chandra; Kathryn E Hulse; Lydia A Suh; James E Norton; Anju T Peters; Leslie C Grammer; Lawrence B Schwartz; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2014-03-15       Impact factor: 10.793

8.  High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids.

Authors:  Wha-Yong Lee; Thomas Southworth; Steven Booth; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 9.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

10.  Allergen-induced airway inflammation and its therapeutic intervention.

Authors:  Paul M O'Byrne
Journal:  Allergy Asthma Immunol Res       Date:  2009-09-25       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.